- Home
- CCG vs ABOS Comparison
CCG vs ABOS Comparison
Compare CCG & ABOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CCG
- ABOS
- Stock Information
- Founded
- CCG 2014
- ABOS 1996
- Country
- CCG China
- ABOS United States
- Employees
- CCG N/A
- ABOS N/A
- Industry
- CCG
- ABOS Biotechnology: Pharmaceutical Preparations
- Sector
- CCG
- ABOS Health Care
- Exchange
- CCG Nasdaq
- ABOS Nasdaq
- Market Cap
- CCG 89.5M
- ABOS 84.2M
- IPO Year
- CCG N/A
- ABOS 2021
- Fundamental
- Price
- CCG $1.50
- ABOS $1.23
- Analyst Decision
- CCG Buy
- ABOS Strong Buy
- Analyst Count
- CCG 1
- ABOS 3
- Target Price
- CCG $350.00
- ABOS $8.00
- AVG Volume (30 Days)
- CCG 796.1K
- ABOS 188.0K
- Earning Date
- CCG 08-28-2025
- ABOS 11-11-2025
- Dividend Yield
- CCG N/A
- ABOS N/A
- EPS Growth
- CCG N/A
- ABOS N/A
- EPS
- CCG N/A
- ABOS N/A
- Revenue
- CCG $444,290,042.00
- ABOS N/A
- Revenue This Year
- CCG N/A
- ABOS N/A
- Revenue Next Year
- CCG $7.06
- ABOS N/A
- P/E Ratio
- CCG N/A
- ABOS N/A
- Revenue Growth
- CCG N/A
- ABOS N/A
- 52 Week Low
- CCG $0.66
- ABOS $0.86
- 52 Week High
- CCG $1.54
- ABOS $3.36
- Technical
- Relative Strength Index (RSI)
- CCG 80.25
- ABOS 39.55
- Support Level
- CCG $0.99
- ABOS $1.34
- Resistance Level
- CCG $1.18
- ABOS $1.47
- Average True Range (ATR)
- CCG 0.16
- ABOS 0.08
- MACD
- CCG 0.04
- ABOS -0.02
- Stochastic Oscillator
- CCG 100.00
- ABOS 7.69
About CCG Cheche Group Inc.
Cheche Group Inc is engaged in the operation of providing insurance transaction services, Software-as-a-Service (SaaS) services and other services in China.. It is China's independent technology-empowered platform for auto insurance transaction services by digital auto insurance transaction premiums and insurance technology companies. The company has reshaped the traditional auto insurance distribution and services value chain to create a digital platform by improving operational efficiencies, reducing transaction costs, and expanding distribution channels. Its business scope ranges from digital insurance transactions, SaaS platforms for insurance intermediaries, AI-driven insurance pricing and underwriting services, auto insurance services for new energy vehicle (NEV) manufacturers, etc.
About ABOS Acumen Pharmaceuticals Inc.
Acumen Pharmaceuticals Inc is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target what it believes to be a key underlying cause of Alzheimer's disease. The company's drug candidate, ACU193, is a subclass monoclonal antibody that selectively targets amyloid-beta oligomers.